Paclitaxel Injection, Powder, Lyophilized, For Suspension
Product Images NDC 75007-041

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paclitaxel (NDC 75007-041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ningbo Shuangcheng Pharmaceutical Co., Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Paclitaxel 01)

FDA Label Image

Image Description (Paclitaxel 02)

FDA Label Image

Image Description (Paclitaxel 03)

FDA Label Image

Image Description (Paclitaxel 04)

FDA Label Image

Image Description (Paclitaxel 05)

Image Description (Paclitaxel 05)
This is a description of a pharmaceutical product that appears to be Pacitaxel Protein-Bound Particles for Injectable Suspension. The product comes in vials containing 100 mg of the medication. The text may also indicate that it is albunin-bound, which is likely a specific formulation or delivery method. Overall, this seems to be a medication used for intravenous administration.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.